We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

98 hedge funds and large institutions have $503M invested in Foundation Medicine, Inc. in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 25

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

9% more funds holding

Funds holding: 9098 (+8)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

16% less capital invested

Capital invested by funds: $599M → $503M (-$96.4M)

39% less call options, than puts

Call options by funds: $4.63M | Put options by funds: $7.54M

Holders
98
Holders Change
+8
Holders Change %
+8.89%
% of All Funds
2.82%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
29
Increased
36
Reduced
25
Closed
21
Calls
$4.63M
Puts
$7.54M
Net Calls
-$2.91M
Net Calls Change
-$750K
Name Holding Trade Value Shares
Change
Change in
Stake
TRV
1
Third Rock Ventures
Massachusetts
$133M -$41.6M -1,642,411 -25%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$71.6M +$45M +1,777,053 +203%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$57.9M +$18M +709,289 +49%
GGHC
4
Gilder Gagnon Howe & Co
New York
$50.8M +$148K +5,833 +0.3%
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$32.2M +$9.58M +377,762 +46%
AI
6
Alphabet Inc
California
$30.9M -$33M -1,300,000 -53%
BCPEM
7
Bain Capital Public Equity Management
Massachusetts
$12M +$11.3M +446,400 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$8.92M +$3.65M +143,992 +77%
Wells Fargo
9
Wells Fargo
California
$8.7M +$831K +32,780 +11%
Artisan Partners
10
Artisan Partners
Wisconsin
$8.38M +$731K +28,820 +10%
BFA
11
BlackRock Fund Advisors
California
$8.27M +$3.35M +132,088 +76%
BAMCO Inc
12
BAMCO Inc
New York
$6.5M -$866K -34,168 -12%
FAM
13
Fred Alger Management
New York
$5.96M -$159K -6,268 -3%
NM
14
Nokota Management
New York
$5.62M
Goldman Sachs
15
Goldman Sachs
New York
$5.21M +$847K +33,395 +21%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$4.72M +$4.44M +175,000 New
State Street
17
State Street
Massachusetts
$4.5M +$1.73M +68,105 +69%
BIT
18
BlackRock Institutional Trust
California
$4.41M +$2.21M +87,033 +114%
DM
19
Deerfield Management
New York
$3.69M -$5.22M -205,900 -60%
PSC
20
Prentiss Smith & Co
Vermont
$2.7M -$35.9K -1,417 -1%
TG
21
TCW Group
California
$2.39M -$548K -21,629 -20%
KCM
22
Kornitzer Capital Management
Kansas
$2.29M -$634K -25,000 -23%
Northern Trust
23
Northern Trust
Illinois
$2.25M -$36.4K -1,437 -2%
BBA
24
Baker Bros. Advisors
New York
$2.11M +$1.98M +78,162 New
TCIM
25
TIAA CREF Investment Management
New York
$1.51M +$587K +23,162 +71%

FMI Hedge Fund Activity: Q2 2014 in Review

98 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2014, worth a combined $503M — down 16% from $599M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new FMI positions and 21 closed out — a net gain of 8 holders — while 36 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $45M. The largest seller was Third Rock Ventures, cutting an estimated $41.6M.

  • 98 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2014, up from 90 in Q1 2014.
  • Funds reported $503M of Foundation Medicine, Inc. stock for Q2 2014, down 16% quarter-over-quarter.
  • 29 funds opened new Foundation Medicine, Inc. positions in Q2 2014 and 21 closed out, a net change of +8 holders.
  • The largest Foundation Medicine, Inc. buyer in Q2 2014 was Fidelity Investments, an estimated $45M added.
  • The largest Foundation Medicine, Inc. seller in Q2 2014 was Third Rock Ventures, an estimated $41.6M sold.

Based on aggregated 13F filings for Q2 2014.